We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Particle Size Not Cholesterol Determines Capacity of HDL to Reduce CVD

By LabMedica International staff writers
Posted on 16 Aug 2016
Results of a recent study suggested that the number and size of high-density lipoprotein (HDL) particles in the blood were better indicators of cardiovascular disease (CVD) risk than was the classical measurement of HDL-cholesterol.

To try to explain why treatments to elevate plasma high-density lipoprotein cholesterol (HDL-C) fail to reduce CVD risk, investigators at the Hebrew University of Jerusalem (Israel) recruited a study population comprising 504 Jerusalem residents (274 Arabs and 230 Jews). More...
The participants' HDL was measured and classified by NMR spectroscopy, and calcification in their coronary arteries (CAC), reflecting the overall burden of coronary atherosclerosis, was determined by multidetector helical CT-scanning.

Results revealed that HDL-C was not protectively associated with CAC, but that HDL particle number (HDL-P) was strongly protectively associated with CAC. Small and medium-sized HDL (MS-HDL-P) and HDL-P accounted for the protective effects of HDL-P. Large HDL-P and average HDL-P size were not significantly associated with CAC. Therefore, MS-HDL-P and HDL-P were better risk markers for CAC than the traditional HDL-C.

"Our findings indicate that HDL-P and MS-HDL-P are better independent markers of coronary artery disease, as reflected by coronary artery calcification, than HDL-C, at least in this bi-ethnic population of Israelis and Palestinians," said first author Dr. Chobufo Ditah, (from Cameroon) a master of public health student at the Hebrew University of Jerusalem. "These findings support previous reports, based on studies in other population groups, suggesting that small dense HDL particles are protectively associated with risk of coronary heart disease. The consistency of this finding in a new population of urban Arabs and Jews, using different disease outcomes and different separation methods, add more strength to those findings."

"With a better understanding of HDL's complexity and a better ability to measure its components, it is now possible to move past HDL-C to more refined measures that better reflect HDL's role in coronary heart disease risk. Based on the accumulating evidence, incorporation of MS-HDL-P or HDL-P into the routine prediction of coronary heart disease risk should be considered," said senior author Dr. Jeremy Kark, professor of epidemiology at the Hebrew University of Jerusalem.

The study was published in the August 2016 issue of the journal Atherosclerosis.

Related Links:
Hebrew University of Jerusalem


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.